← Eichor
Condition: Advanced Kras G12D Mutant Solid Tumors Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Advanced Kras G12D Mutant Solid Tumors

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Phase I Study of HRS-6093 in Participants With Advanced Solid Tumors Harboring KRAS G12D Mutations
Phase 1 · 2 location(s) · Jiangsu HengRui Medicine Co., Ltd. · NCT07134998A First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS Mutations
Phase 1/Phase 2 · 1 location(s) · Blueprint Medicines Corporation · NCT07629960A Study of GFH375 in Patients With Advanced Solid Tumors With KRAS G12D Mutations
Phase 1/Phase 2 · 20 location(s) · Genfleet Therapeutics (Shanghai) Inc. · NCT06500676A Phase I/II Study of ABSK141 in Patients With Advanced Solid Tumors ( ABSK141-101 )
Phase 1/Phase 2 · 1 location(s) · Abbisko Therapeutics Co, Ltd · NCT07417189A Phase I/IIa Study of JAB-23E73 in Patients With Advanced Solid Tumors Harboring KRAS Gene Alteration
Phase 1/Phase 2 · 32 location(s) · Jacobio Pharmaceuticals Co., Ltd. · NCT06959615JAB-23E73 in Adult Participants With Advanced Solid Tumors With KRAS Alteration
Phase 1/Phase 2 · 4 location(s) · Jacobio Pharmaceuticals Co., Ltd. · NCT06973564BBO-11818 in Adult Subjects With KRAS Mutant Cancer
Phase 1 · 17 location(s) · TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics) · NCT06917079Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
Phase 1 · 17 location(s) · Revolution Medicines, Inc. · NCT06040541
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.